News tagged with exenatide
Related topics: type 2 diabetes
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...
Parkinson's & Movement disorders May 20, 2013 | not rated yet | 0
(HealthDay)—The drug Byetta, approved for adults with type 2 diabetes, appears to help severely obese teens lose some weight, a small study found.
Pediatrics Feb 05, 2013 | 5 / 5 (1) | 0 |
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according ...
Pediatrics Feb 04, 2013 | not rated yet | 0
A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.
Diabetes Nov 06, 2012 | 5 / 5 (2) | 0 |
(Medical Xpress)—Medications used to treat hypertension, diabetes and skin conditions could be doubling as treatments for Alzheimer's within 10 years according to researchers. A groundbreaking new study ...
Alzheimer's disease & dementia Nov 01, 2012 | not rated yet | 0 |
A drug made from the saliva of the Gila monster lizard is effective in reducing the craving for food. Researchers at the Sahlgrenska Academy, University of Gothenburg, have tested the drug on rats, who after ...
Neuroscience May 15, 2012 | 5 / 5 (2) | 1
Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.
Inflammatory disorders Nov 02, 2011 | not rated yet | 0
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according ...
Medications Sep 16, 2011 | 5 / 5 (3) | 0 |